专利便秘仪器治疗慢传输型便秘患者的疗效观察  

Efficacy observation of patented constipation apparatus in the treatment of patients with slow transit constipation

作　　者：赖庆勇[1] 李婷珊[1] 郑少康[1] 马普伟[1] 徐洪侠 LAI Qing-yong;LI Ting-shan;ZHENG Shao-kang(Anorectal Department,Zhongshan Hospital of Traditional Chinese Medicine,Zhongshan 528400,China)

机构地区：[1]广东省中山市中医院肛肠科,528400

出　　处：《中国实用医药》2022年第18期1-5,共5页China Practical Medicine

基　　金：广东省中山市第一批社会公益与基础研究项目(项目编号:2020B1136)。

摘　　要：目的 观察本院专利便秘仪器便秘舒通治疗仪通过轻柔鼓气推压肠道、腹部按摩、便秘穴位刺激等促进肠道运动对慢传输型便秘(STC)患者的治疗效果。方法 160例STC患者,随机分为常规组和观察组,每组80例。常规组患者采用枸橼酸莫沙必利片治疗,观察组患者在常规组治疗基础上增加便秘舒通治疗仪腹部理疗。比较两组患者平均每周自发完全排便次数(SCBM)、便秘患者症状自评量表(PAC-SYM)评分、Bristol粪便性状量表(BSFS)评分、胃肠道生活质量指数量表(GIQLI)评分、临床疗效。结果 治疗4周后,观察组患者SCBM(5.2±1.8)次/周、BSFS评分(3.63±0.88)分、GIQLI评分(120.1±17.0)分高于常规组的(2.1±1.0)次/周、(2.05±0.75)分、(80.4±14.5)分, PAC-SYM评分(1.3±0.4)分低于常规组的(2.4±0.5)分,差异具有统计学意义(P<0.05)。观察组患者治疗总有效率为92.50%,高于常规组的58.75%,差异具有统计学意义(P<0.05)。结论 在常规口服枸橼酸莫沙必利片治疗STC的基础上加用专利便秘仪器便秘舒通治疗仪进行腹部理疗能加快胃肠运动排泄过程,增加SCBM,有效缓解患者便秘症状,明显提高临床疗效。Objective To observe the therapeutic effect of patented constipation Shutong therapeutic apparatus to promote intestinal peristalsis on patients with slow transit constipation(STC) by promoting intestinal peristalsis of gentle air-blowing, massages the abdomen and stimulates constipation acupoints. Methods A total of 160 STC patients were randomly divided into conventional group and observation group, with 80 cases in each group. Patients in the conventional group were treated with mosapride citrate tablets, while patients in the observation group were treated with abdominal physiotherapy with the patented constipation Shutong therapeutic apparatus on the basis of the conventional group. The spontaneous complete bowel movements(SCBM), patient assessment of constipation symptom(PAC-SYM) score, Bristol stool form scale(BSFS) score, and gastrointestinal quality of life index(GIQLI) score, clinical efficacy were compared between the two groups. Results After 4 weeks of treatment, the SCBM(5.2±1.8) times/week, BSFS score(3.63±0.88) points and GIQLI score(120.1±17.0) points of the observation group were higher than(2.1±1.0) times/week,(2.05±0.75) points and(80.4±14.5) points of the conventional group;the PAC-SYM score(1.3±0.4) points of the observation group was lower than(2.4±0.5) points of the conventional group;all the differences were statistically significant(P<0.05).The total effective rate of the observation group was 92.50%, which was higher than 58.75% of the conventional group, and the difference was statistically significant(P<0.05). Conclusion In addition to the conventional oral mosapride citrate tablets for the treatment of STC, the addition of abdominal physiotherapy with the patented constipation Shutong therapeutic apparatus can accelerate the movement and excretion of gastrointestinal content,increase the SCBM, effectively relieve patients’ constipation symptoms, and significantly improve the clinical efficacy.

关 键 词：慢传输型便秘 专利便秘仪器 枸橼酸莫沙必利片 

分 类 号：R574.62[医药卫生—消化系统]